SteadyMed to Present at the Annual Ladenburg Thalmann 2016 Healthcare Conference
September 20, 2016 08:30 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., Sept. 20, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...
SteadyMed to Present at the 18th Annual Rodman & Renshaw Global Investment Conference
September 06, 2016 11:36 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...
SteadyMed Announces Completion of Pre-NDA Submission Manufacturing Activities
September 01, 2016 08:30 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., Sept. 01, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...
SteadyMed Provides Corporate Update and Reports Second Quarter 2016 Financial Results
August 15, 2016 17:09 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., Aug. 15, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...
SteadyMed Raises up to $32 Million in Private Placement
July 29, 2016 15:04 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., July 29, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...
SteadyMed to Present at the 2016 JMP Securities Life Sciences Conference
June 21, 2016 09:00 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., June 21, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...
UPDATE -- SteadyMed and the Pulmonary Hypertension Association Launch Campaign to Highlight Unique and Inspirational Faces Behind PH
June 17, 2016 09:56 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., June 17, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...
SteadyMed and the Pulmonary Hypertension Association Launch Campaign to Highlight Unique and Inspirational Faces Behind PH
June 16, 2016 08:39 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., June 16, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...
SteadyMed Provides Corporate Update and Reports First Quarter 2016 Financial Results
May 11, 2016 08:30 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., May 11, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...
SteadyMed Announces Public Availability of PTAB Decision to Institute Inter Partes Review Proceedings
April 25, 2016 08:30 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., April 25, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...